Revance(RVNC) - 2019 Q2 - Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2019 Results Earnings Conference Call August 5, 2019 4:30 PM ET Company Participants Jeanie Herbert - Senior Director of IR & Corporate Communications Daniel Browne - Co-Founder, President, CEO Tobin Schilke - CFO & Principal Accounting Officer Conference Call Participants Annabel Samimy - Stifel Ken Cacciatore - Cowen & Company Seamus Fernandez - Guggenheim David Amsellem - Piper Jaffray David Maris - Wells Fargo Tim Lugo - William Blair Douglas Tsao - H.C. Wainw ...